The Global Generics & Biosimilars Awards is the one night of the year when the off-patent pharmaceutical industry’s greatest achievements are put in the spotlight.
Taking place November 10, 2021 in Milan, Italy, the Global Generics & Biosimilars Awards 2021 is free to enter and attend and will reward companies across the off-patent industry – including small-molecule generics, biosimilars and value-added medicines – by recognizing their successes over the past year.
Our awards categories crown the industry’s leading companies, both on a global and regional basis; highlight achievements in biosimilars and value-added medicines; and also recognize the industry’s biggest deals, regulatory milestones and company leaders.
API suppliers and other industry partners also have their own categories in which to compete for recognition, while companies are also presented with awards for their CSR activities, their intellectual property strategies and other business development initiatives.
As the world continues to grapple with the COVID-19 pandemic, there has perhaps never been a more appropriate time to recognize the ongoing efforts made by the worldwide off-patent industry to provide access to quality, effective medicines at affordable prices around the globe.
Entry Deadline is July 30, 2021.
Entry Deadline: July 30, 2021
Awards Ceremony: November 10, 2021
In communities around the world affected by chronic poverty, conflict or disasters, easily treatable diseases can mean chronic pain, poor quality of life or even a death sentence. International Health Partners (IHP) was founded in 2003 with a vision to radically enhance access to medicine to the world’s most vulnerable people. IHP enable targeted donations of medicines from a network of over 60 healthcare companies across Europe, and coordinate the safe and responsible supply of these to disaster hit and vulnerable communities across the world. IHP are the only organisation working to this model in the UK. In the last three years IHP have sent over 8.2 million treatments, with a value of over £34.5 million.